Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
618.00    5.00 (0.82%)
Bid:
617.00
Ask:
619.00
Spread: 2.00 (0.324%)
Market Cap: £685.83m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

AGM Statement

28 May 2021 07:00

RNS Number : 1049A
Barr(A.G.) PLC
28 May 2021
 

 28 May 2021

 

A.G. BARR p.l.c.AGM Statement

 

A.G. BARR p.l.c.,"the Company", which produces and markets some of the UK's leading drinks brands, is holding its Annual General Meeting today at 12pm BST at which the following comments will be made :

 

"We are pleased to announce that trading in the year to date is in line with the Board's expectations.

 

Despite lockdown restrictions being in place across much of the first quarter, Barr Soft Drinks trading has been relatively strong since the start of the new financial year. As lockdown restrictions have eased we have seen a positive impact on both our sales volume and mix, with a shift back towards 'drink now', hospitality and leisure. Our soft drinks trading momentum has been supported by encouraging new product launches - Rubicon RAW Energy in particular achieving promising initial customer listings and consumer feedback.

While the pace and extent of the reopening of the hospitality sector varies by region, our Funkin business is already beginning to see the benefits, delivering on-trade sales that provide optimism for the sector's recovery. Across the take-home channel, the strong performance of our Funkin ready to drink cocktails during 2020 is continuing, with an increase in both customer listings and new consumers enjoying Funkin cocktails at home.

Current trading is encouraging and we have clear plans to further invest in our brands, with exciting consumer engagement and marketing activity planned across the year.

Our balance sheet remains strong and we remain committed to our plan to recommence dividend payments during the current financial year. A further update in this regard will be provided in our half year trading update in early August 2021.

Whilst there remains some uncertainty in the short term as pandemic related restrictions ease, we believe we are well placed to drive the growth of the business and remain confident in the Company's prospects for the full year."

For more information, please contact:

 

A.G. BARR 0330 390 3900 Instinctif Partners  020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next trading update - Aug 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGZKVNVGMZM
Date   Source Headline
8th Sep 20222:08 pmRNSDirector/PDMR Shareholding
31st Aug 202210:29 amRNSNotice of Interim Results Date
8th Aug 20221:05 pmRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSTrading Update
11th Jul 202210:32 amRNSDirector/PDMR Shareholding
16th Jun 202210:14 amRNSDirector/PDMR Shareholding
16th Jun 202210:04 amRNSDirector/PDMR Shareholding
15th Jun 202210:23 amRNSDirector/PDMR Shareholding
13th Jun 20221:42 pmRNSDirector/PDMR Shareholding
13th Jun 20221:40 pmRNSDirector/PDMR Shareholding
8th Jun 20229:53 amRNSDirectorship
27th May 20221:55 pmRNSResult of AGM
23rd May 20229:55 amRNSDirector/PDMR Shareholding
11th May 20228:53 amRNSDirector/PDMR Shareholding
26th Apr 20229:08 amRNSAnnual Financial Report / Notice of AGM
11th Apr 20221:11 pmRNSDirector/PDMR Shareholding
11th Apr 20228:51 amRNSDirector/PDMR Shareholding
11th Apr 20228:45 amRNSDirector/PDMR Shareholding
30th Mar 20227:00 amRNSDirectorate Change
29th Mar 20222:34 pmRNSDirector/PDMR Shareholding
29th Mar 20229:37 amRNSCorrection: Final results year ended 30 Jan 2022
29th Mar 20227:00 amRNSFinal results for the year ended 30 January 2022
18th Mar 20229:02 amRNSHolding(s) in Company
8th Mar 20222:14 pmRNSDirector/PDMR Shareholding
9th Feb 20227:56 amRNSDirector/PDMR Shareholding
4th Feb 20228:32 amRNSHolding(s) in Company
4th Feb 20228:27 amRNSHolding(s) in Company
1st Feb 20227:00 amRNSTrading Update
26th Jan 202210:35 amRNSNotice of Trading Update
11th Jan 202211:28 amRNSDirector/PDMR Shareholding
8th Dec 202112:59 pmRNSDirector/PDMR Shareholding
6th Dec 20217:00 amRNSInvestment in MOMA Foods Limited
29th Nov 20217:00 amRNSTrading Update
8th Nov 20212:15 pmRNSDirector/PDMR Shareholding
3rd Nov 20211:21 pmRNSDirector/PDMR Shareholding
3rd Nov 20219:37 amRNSDirector/PDMR Shareholding
1st Nov 202112:50 pmRNSDirector/PDMR Shareholding
11th Oct 20212:15 pmRNSDirector/PDMR Shareholding
11th Oct 20218:12 amRNSDirector/PDMR Shareholding
1st Oct 20218:49 amRNSDirector/PDMR Shareholding
1st Oct 20218:33 amRNSDirector/PDMR Shareholding
28th Sep 20217:00 amRNSInterim results
8th Sep 202111:39 amRNSDirector/PDMR Shareholding
31st Aug 202110:37 amRNSNotice of Interim Results Date
9th Aug 202111:21 amRNSDirector/PDMR Shareholding
3rd Aug 20217:00 amRNSH1 trading update to 1 August 2021
20th Jul 20217:00 amRNSTrading Update
19th Jul 20212:22 pmRNSHolding(s) in Company
9th Jul 20217:55 amRNSDirector/PDMR Shareholding
6th Jul 20213:32 pmRNSDirector/PDMR Shareholding - AMENDMENT

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.